How the NIH Shapes Drug Development

Send us Fan MailIn this episode, we reveal how the National Institutes of Health (NIH) funnels your tax dollars to big pharma through the Bayh-Dole Act. Passed in 1980, the Bayh-Dole Act allows universities, small businesses, and non-profits to own inventions made with federal funding and license them to private companies. This has led to significant medical advancements, but also raised questions about who benefits the most.The NIH has earned up to $2 billion in royalties from 34 drugs sold from 1991-2019. Often, NIH’s investment in drug development is comparable to or greater than that of the pharmaceutical industry. This raises concerns about whether public funds are truly serving the public or primarily boosting pharmaceutical profits.Want to learn more and see the resources I used? Visit my website for detailed information and links to all the references.Join the conversation by subscribing, commenting, and sharing your thoughts. Together, we can drive change for a more transparent system.#BigPharma #NIH #BayhDoleAct #TaxDollars #HealthcareMore from Jessie Virga:Website: https://www.jessievirga.comW3 Magazine: https://www.thew3mag.comMB Security: https://www.mbsecurityusa.comK&L Animal Rescue: https://www.klrescue.orgThis content is for educational and informational purposes only and is not legal, medical, security, financial, fitness, business, or professional advice. Some links may be affiliate links.#DrVirgaPodcast #Preparedness #Security #Resilience #W3Magazine